HB NEW YORK. Pfizer pays a price of 14.25 dollars per share. The leadership of King Pharmaceuticals have already approved the bid. Pfizer had last year’s competitors Wyeth for around 67 billion dollars and taken over, thereby securing a place in the branch tip.
The acquisition of King Pharmaceuticals will bring annual savings of at least 200 million dollars. On its forecast for this year held for the group. In premarket trading, the U.S. share of King Pharmaceuticals jumped 39.3 percent to $ 14.14 in the air.